Liver transplantation in association with hepatocellular carcinoma: An update of the international tumor registry

Liver Transplantation

Volumn 8, Issue 9, 2002, Pages 736-748

  Molmenti, Ernesto P ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGISTER; REVIEW; TUMOR VOLUME;

EID: 0036711999     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.34879     Document Type: Article

References (119)

1. Hepatobiliary malignancies. Primary hepatic malignant neoplasms
2. Primary hepatocellular carcinoma
3. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: Epidemiologic considerations
4. The hepatitis-B virus and hepatocellular carcinoma
5. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association
6. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal West Africa
7. Hepatitis C virus and hepatocellular carcinoma
8. Uber das primate carcinom de leber
9. Pathology of hepatocellular carcinoma
10. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors
11. DNA analysis of hepatocellular carcinoma and clinicopathologic implications
12. Cancer and liver transplantation
13. Percutaneous fine-needle aspiration of portal vein thrombi as a staging technique for hepatocellular carcinoma. Cytologic findings of 46 patients
14. Needle tract recurrence of hepatocellular carcinoma after liver transplantation
15. Hepatocellular cancer in liver transplantation
16. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence
17. Surgical therapy for hepatocellular carcinoma
18. Preoperative needle biopsy and long-term outcome of patients undergoing resection for hepatocellular carcinoma
19. Primary liver cell carcinoma
20. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival
21. Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma
22. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
23. Liver transplantation for hepatocellular carcinoma. A registry report of the impact of tumor characteristics on outcome
24. Clinical trials in primary hepatocellular carcinoma: Current status and future directions
25. Hepatic resection for hepatocellular carcinoma
26. Resections of recurrence in the liver of primary and secondary liver cancers
27. Personal experience with 411 hepatic resections
28. Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis
29. Liver resections in cirrhotic patients: A Western experience
30. Hepatic resection in 128 patients: A 24-year experience
31. Clinical experience with 118 hepatic resections for hepatocellular carcinoma
32. Hepatic resection in 120 patients with hepatocellular carcinoma
33. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
34. Postresection prognosis of patients with hepatocellular carcinoma
35. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis
36. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
37. Results of 280 liver resections for hepatocellular carcinoma
38. Primary hepatic malignancy: Surgical management and determinants of survival
39. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma
40. Approach to primary liver cancer
41. Hepatoma in the noncirrhotic liver
42. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features
43. Hepatocellular carcinoma: Importance of histologic classification as a prognostic factor
44. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver
45. An analysis of 412 cases of hepatocellular carcinoma at a Western center
46. Long-term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features
47. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment
48. Fibrolamellar hepatoma
49. Fibrolamellar carcinoma of the liver
50. Experience in Hepatic Transplantation
51. Indications and assessment for orthotopic liver transplantation
52. Is liver transplantation justified for the treatment of hepatic malignancies?
53. Is there a place for liver grafting for malignancy?
54. Disease recurrence following liver transplantation
55. Role of liver transplantation in cancer therapy
56. Liver transplantation for malignant disease. Results in 93 consecutive patients
57. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence
58. Experience with transplantation in the treatment of liver cancer
59. Hepatic transplantation for primary and metastatic cancers of the liver
60. The surgical treatment of primary hepatobiliary malignancy
61. Current treatment modalities for hepatocellular carcinoma
62. Liver transplantation in the treatment of primary liver cancer
63. Primary hepatic malignancy: The role of liver transplantation
64. Liver transplantation for hepatocellular carcinoma: Clinical results and future aspects
65. Liver transplantation for primary hepatic cancer
66. Indications for liver transplantation in hepatobiliary malignancy
67. Hepatic resection versus transplantation for hepatocellular carcinoma
68. Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients
69. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study
70. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
71. The current status of liver transplantation for primary hepatic malignancy
72. Prognosis of hepatocellular carcinoma: The BCLC staging classification
73. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
74. Liver transplantation for primary hepatocellular carcinoma: Tumor size and number determine outcome
75. Liver transplantation for hepatocellular carcinoma
76. Total hepatectomy and liver transplantation for hepatocellular carcinoma. A single center experience with 72 patients
77. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation
78. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
79. American joint Committee on Cancer: Liver (including intrahepatic bile ducts)
80. Liver grafting for malignant liver tumors
81. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma
82. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation
83. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A
84. Cells responsible for tumor surveillance in man: Effects of radiotherapy, chemotherapy, and biologic response modifiers
85. Evaluation of results of liver transplantation: Experience based on a series of 1052 transplantations
86. Survival after liver transplantation in patients with hepatocellular carcinoma
87. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma
88. Neoadjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma
89. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis
90. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis
91. Recurrent hepatocellular carcinoma after liver transplantation: Spectrum of CT findings and recurrence patterns
92. Indications and role of liver transplantation for malignant tumors
93. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation
94. Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation
95. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis
96. Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma
97. Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective
98. Liver transplantation for hepatocellular carcinoma?
99. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
100. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: Biologic and therapeutic implications
101. Familial amyloidotic polyneuropathy: Domino liver transplantation
102. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
103. Treatment of hepatomas in cirrhotic patients with radiofrequency thermal ablation
104. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection
105. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply
106. A 5-year study of cryosurgery in the treatment of liver tumors
107. Place of cryosurgery in the treatment of malignant liver tumors
108. Nonresectional therapies for hepatocellular carcinoma
109. Hepatocellular carcinoma
110. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center
111. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma
112. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
113. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit?
114. Chemotherapy of primary liver cancer
115. Vascular changes and hemodynamics in hepatocellular carcinoma
116. Liver transplantation for hepatocellular carcinoma
117. Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma